Skip to main content
    I

    Immunocore Holdings Ltd (IMCR)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $28.88
    -1.06 (-3.54%)

    Market Cap: $1.55B

    Last updated: Nov 17, 2026 at 11:05 AM ET

    Immunocore Holdings Ltd (IMCR) Competitors

    Updated Nov 17, 2026. Similar companies are ranked by business profile, size, sector and industry; metrics come from company filings and market prices.

    The companies most similar to Immunocore Holdings are Xencor (XNCR), Immatics NV (IMTX) and MoonLake Immunotherapeutics (MLTX). By market cap, Immunocore Holdings ranks 6th of the 13 companies on this page; Xencor (XNCR) is the largest at $2.78B.

    Peer Comparison

    IMCR's ROIC of -0.5% is above the peer median of -54.6%, and its revenue growth of -1.4% is below the median of 0.0%. Like the median peer, it pays no dividend.

    CompanyMarket capP/EP/SNet marginROICRev growthDiv yield
    Immunocore Holdings (IMCR)$1.55BN/A2.8x-7.5%-0.5%-1.4%0.00%
    Xencor Inc (XNCR)$2.78BN/A13.5x-58.8%-17.3%454.9%0.00%
    Immatics NV (IMTX)$972.99MN/A17.7x0.0%N/A33.5%0.00%
    MoonLake Immunotherapeutics (MLTX)$1.06BN/AN/A0.0%-54.6%0.0%0.00%
    Replimune Group Inc (REPL)$2.08BN/AN/A0.0%-65.4%0.0%0.00%
    Vir Biotechnology Inc (VIR)$1.71BN/A5.4x-61.0%N/A19582.0%0.00%
    Nurix Therapeutics Inc (NRIX)$1.69B6.4x2.3x42.0%N/A8426.0%0.00%
    Inhibrx Biosciences, Inc. (INBX)$1.23BN/A610.4x0.0%-66.0%-100.0%0.00%
    Corvus Pharmaceuticals Inc (CRVS)$897.52MN/AN/A0.0%N/A0.0%0.00%
    Vor Biopharma Inc (VOR)$1.19BN/AN/A0.0%N/A0.0%0.00%
    Tyra Biosciences Inc (TYRA)$1.38BN/AN/A0.0%N/A0.0%0.00%
    Silence Therapeutics PLC (SLN)$1.23BN/A882.5x0.0%N/A197.2%0.00%
    Fortrea Holdings Inc. (FTRE)$1.95B26.0x0.7x-2.6%1.8%-1.4%0.00%
    Peer median$1.31B16.2x13.5x0.0%-54.6%0.0%0.00%
    Market data as of Nov 17, 2026. Net margin covers the trailing 12 months, Rev growth compares the latest quarter with a year earlier and Div yield is the forward yield. P/E uses earnings per share for the last 12 months as companies report it, often adjusted, so it can show beside a negative net margin, which uses net income. P/E and P/S show N/A when those earnings or sales are negative or missing, or the multiple is above 1,000x.

    Similar Companies

    These are the 12 companies most similar to Immunocore Holdings, ranked by how closely their business, size, sector and industry match. All 12 are in one industry, Biotechnology.

    CompanyAboutPeers
    Xencor Inc (XNCR)
    Xencor, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of cytokine and monoclonal antibody therapies designed...
    XNCR competitors
    Immatics NV (IMTX)
    Immatics NV, a clinical-stage biopharmaceutical company, focuses on the discovery and development of T-cell receptor (TCR) -based immunotherapies...
    IMTX competitors
    MoonLake Immunotherapeutics (MLTX)
    MoonLake Immunotherapeutics is an innovative biotechnology firm dedicated to advancing therapies for chronic inflammatory diseases through its proprietary drug...
    MLTX competitors
    Replimune Group Inc (REPL)
    Replimune Group, Inc., a biotechnology company, develops oncolytic immunogenic therapies to treat cancer. The company is headquartered in Woburn, Massachusetts.
    REPL competitors
    Vir Biotechnology Inc (VIR)
    Vir Biotechnology, Inc., a clinical-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases.
    VIR competitors
    Nurix Therapeutics Inc (NRIX)
    Nurix Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development...
    NRIX competitors
    Inhibrx Biosciences, Inc. (INBX)
    Inhibrx, Inc., a clinical-stage biotechnology company, is focused on developing a line of new biological therapeutic candidates.
    INBX competitors
    Corvus Pharmaceuticals Inc (CRVS)
    Corvus Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of immuno-oncology therapies.
    CRVS competitors
    Vor Biopharma Inc (VOR)
    Vor Biopharma, Inc., an early stage cell therapy company, develops hematopoietic stem cell (eHSC) therapies designed for cancer patients.
    VOR competitors
    Tyra Biosciences Inc (TYRA)
    Tyra Biosciences, Inc., a preclinical-stage biopharmaceutical company, focuses on developing therapies to overcome tumor resistance and improve outcomes...
    TYRA competitors
    Silence Therapeutics PLC (SLN)
    Silence Therapeutics plc, a biotechnology company, is focused on the discovery and development of new ribonucleic acid (RNA) therapies in hematology...
    SLN competitors
    Fortrea Holdings Inc. (FTRE)
    Fortrea Holdings Inc. provides clinical development and patient access solutions to the life sciences industry.
    FTRE competitors

    Frequently Asked Questions About IMCR

    Who are Immunocore Holdings' main competitors?

    The companies most similar to Immunocore Holdings include Xencor (XNCR), Immatics NV (IMTX), MoonLake Immunotherapeutics (MLTX), Replimune Group (REPL) and Vir Biotechnology (VIR), listed from the closest match.

    Who is Immunocore Holdings' biggest competitor?

    Xencor (XNCR) is both the largest of the similar companies at $2.78B and the closest match by business profile, size, sector and industry.

    How does IMCR stock compare with its competitors?

    IMCR's P/S is 2.8x against a peer median of 13.5x; its net margin is -7.5% against a peer median of 0.0%.

    Which of Immunocore Holdings' competitors pays a higher dividend?

    Immunocore Holdings pays no dividend. None of the similar companies with available yields has a higher forward dividend yield.

    Is Immunocore Holdings bigger than its competitors?

    No. Immunocore Holdings is 6th by market cap among the 13 companies on this page; the largest is Xencor (XNCR) at $2.78B.